meet jonathan

Jonathan embodies drive and ambition

Jonathan is widely known as “the car guy,” and rightly so. But when he’s not detailing a hot rod, he’s studying the details of his Hemophilia A treatment. That’s why he worked with his doctor, and made the switch from ADVATE® to ELOCTATE.

*ELOCTATE has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.

Q&A

How long have you been working on cars?

When I was a kid, my grandfather had a mechanic shop. I fell in love, and the rest is history.

What about ELOCTATE led you to switch from ADVATE®?

What intrigued me was the extended half-life and the possibility of an infusion schedule up to five days. I mean, everybody is different, but once I worked with my doctor I realized this was the best choice for me.

How’s it working out for you, so far?

It’s great. I went from infusing every other day on my previous standard half life factor to infusing every 4 days on ELOCTATE. And I’m working with my healthcare team to extend to every 5 days. But kinda like cars, each one of us is a different make, a different model, and requires different, specialized care.

So, what’s next for “the car guy”?

I once built a car from scratch. It might be time for a new one.

Note: Patient stories reflect the real-life experiences of persons diagnosed with hemophilia A who have been prescribed ELOCTATE. However, individual experiences may vary. Patient stories are not necessarily representative of what another person using ELOCTATE may experience. Talk to your healthcare provider about what's right for you.

Hear it from
Jonathan himself

Hear it from
Jonathan himself

The recommended starting regimen is 50 IU/kg every 4 days as directed by your doctor. In children under 6 years of age, the recommended starting regimen is 50 IU/kg administered twice weekly. The regimen can be adjusted based on your body's individual response.

×

INDICATION ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

Important Safety Information and Indication  INFORMACIÓN DE SEGURIDAD IMPORTANTE INDICACIONES 

IMPORTANT SAFETY INFORMATION INFORMACIÓN DE SEGURIDAD IMPORTANTE INDICACIONES

Do not use ELOCTATE if you have had an allergic reaction to it in the past. No use ELOCTATE si ha tenido una reacción alérgica a este en el pasado.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII. Informe a su proveedor de atención médica si tiene o ha tenido algún problema médico; toma algún medicamento, incluidos medicamentos recetados y de venta libre, suplementos o medicamentos a base de hierbas; tiene alergias; está en período de lactancia; está embarazada o tiene intención de quedar embarazada; o si le han indicado que tiene inhibidores (anticuerpos) del factor VIII.

INDICATION INDICACIONES

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery. ELOCTATE® es un medicamento inyectable que se usa para ayudar a controlar y prevenir la hemorragia en personas con hemofilia A (deficiencia congénita del factor VIII). Su proveedor de atención médica le podría recetar ELOCTATE cuando se opere.

Important Safety Information and Indication  INFORMACIÓN DE SEGURIDAD IMPORTANTE INDICACIONES 

IMPORTANT SAFETY INFORMATION INFORMACIÓN DE SEGURIDAD

Do not use ELOCTATE if you have had an allergic reaction to it in the past. No use ELOCTATE si ha tenido una reacción alérgica a este en el pasado.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII. Informe a su proveedor de atención médica si tiene o ha tenido algún problema médico; toma algún medicamento, incluidos medicamentos recetados y de venta libre, suplementos o medicamentos a base de hierbas; tiene alergias; está en período de lactancia; está embarazada o tiene intención de quedar embarazada; o si le han indicado que tiene inhibidores (anticuerpos) del factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives. Pueden producirse reacciones alérgicas con ELOCTATE. Llame a su proveedor de atención médica o busque tratamiento de emergencia inmediatamente si presenta alguno de los siguientes síntomas: dificultad para respirar, opresión en el pecho, hinchazón de la cara, erupciones o urticaria.

Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly. Su organismo también puede producir anticuerpos denominados “inhibidores” contra ELOCTATE, que pueden impedir que este actúe correctamente.

Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. Los efectos secundarios frecuentes adicionales de ELOCTATE son dolor de cabeza, erupciones, dolor articular, dolor muscular y malestar general.

If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk. Si tiene factores de riesgo para el desarrollo de coágulos sanguíneos anómalos en su cuerpo, como un catéter venoso permanente, es posible que el tratamiento con factor VIII aumente este riesgo.

These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE. Estos no son todos los efectos secundarios posibles de ELOCTATE. Hable inmediatamente con su proveedor de atención médica sobre cualquier efecto secundario que le moleste o persista, o si la hemorragia no se controla después de usar ELOCTATE.

INDICATION INDICACIONES

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery. ELOCTATE® es un medicamento inyectable que se usa para ayudar a controlar y prevenir la hemorragia en personas con hemofilia A (deficiencia congénita del factor VIII). Su proveedor de atención médica le podría recetar ELOCTATE cuando se opere.

Please see Full Prescribing Information

CONSULTE LA INFORMACIÓN DE PRESCRIPCIÓN COMPLETA en inglés

POR FAVOR VER LA INFORMACIÓN DEPRESCRIPCIÓN COMPLETA en español

MANUFACTURED BY FABRICADO PARA

Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA Waltham, MA 02451 EE. UU.
U.S. License #2078 U.S. Licencia #2078

Click here to learn more about Sanofi's commitment to fighting counterfeit drugs. HAGA CLIC AQUÍ PARA OBTENER MÁS INFORMACIÓN SOBRE EL COMPROMISO DE SANOFI PARA COMBATIR LOS MEDICAMENTOS FALSIFICADOS.